Download in electronic PDF format for $25



Search the Complete Journal Archives

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures

Author(s):  Foushee Jaime A,Meredith Pmichaele,Fox Laura M,Grace EdwardE

Issue:  Jul/Aug 2016 - Volume 20, Number 4
View All Articles in Issue

Abstract:  Parenteral beta-blocker therapy via continuous infusion has shown promising results for improved outcomes for patients with septic shock. As patients with septic shock may require multiple intravenous medications, compatibility is necessary to co-infuse these medications through a y-site connector. The purpose of this study was to examine the physical compatibility of select intravenous drugs used for patients with septic shock combined with various intravenous beta-blockers including esmolol, labetalol, and metoprolol through a simulated y-site infusion. The tested drugs included albumin, levothyroxine, acetaminophen, esomeprazole, doripenem, epinephrine, ibuprofen, norepinephrine, levofloxacin, cefepime, ciprofloxacin, meropenem, cisatracurium, and hydrocortisone. Equal volumes of normal saline, esmolol, labetalol, and metoprolol were combined with each test drug at maximum or commercially available concentrations as appropriate used clinically in intensive care units.The samples were examined visually against a white and black background andalso using turbidimetric measurements to determine physical compatibility.Beginning immediately after mixing, observations and analyses were taken over a one-hour period at 15-minute intervals. Each test was performed in triplicate. Many of the test drugs demonstrated visual and/or turbidimetric physical compatibility when combined with esmolol, labetalol, or metoprolol during a simulated y-site infusion. Albumin, cefepime, and hydrocortisone demonstrated physical incompatibility when combined with labetalol and should not be co-infused with labetalol. Esomeprazole and ibuprofen demonstrated physical incompatibility when combined with esmolol and labetalol and should not be co-infused with either beta-blocker. Esmolol and ciprofloxacin mixtures exhibited a statistically significant difference from control solutions and should not be co-infused.

Related Keywords: Jaime A. Foushee, PharmD, BCPS, Pmichaele Meredith, Laura M. Fox, PhD, Edward E. Grace, PharmD, BCPS, AQ-ID, AAHIVP, Y-site administration, beta-blockers, septic shock, sepsis, tachycardia, intensive care unit, ICU, drug admixtures, drug compatibility, esmolol, labetalol, metoprolol, albumin, levothyroxine, acetaminophen, esomeprazole, doripenem, epinephrine, ibuprofen, norepinephrine, levofloxacin, cefepime, ciprofloxacin, meropenem, cisatracurium, hydrocortisone

Related Categories: INFUSION, PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE Jul/Aug 2016 328-332 Buy
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher Jul/Aug 2002 311-315 Buy
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Nov/Dec 2007 520-524 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A Mar/Apr 2008 156-160 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P May/Jun 2002 230-233 Buy
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma Jan/Feb 2001 69-72 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Trusley Craig, Kupiec Thomas C, Trissel Lawrence A May/Jun 2006 230-233 Buy
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C May/Jun 2016 236-238 Buy